ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Molecular and Cellular Cardiology

• Publication date

  2017-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.yjmcc.2016.12.003PMID 27986444PMCID PMC5944298
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults.

  2016cited by this paper
• Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.

  2016cited by this paper
• Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap

  2016cited by this paper
• Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial

  2016cited by this paper
• Short term omega-3 polyunsaturated fatty acid supplementation induces favorable changes in right ventricle function and diastolic filling pressure in patients with chronic heart failure; A randomized clinical trial.

  2016cited by this paper
• Omega-3 polyunsaturated fatty acid biomarkers and coronary heart disease: pooling project of 19 cohort studies

  2016cited by this paper
• Monocyte and macrophage subsets along the continuum to heart failure: Misguided heroes or targetable villains?

  2015cited by this paper
• Eicosapentaenoic acid upregulates VEGF-A through both GPR120 and PPARγ mediated pathways in 3T3-L1 adipocytes.

  2015cited by this paper
• Epoxyeicosatrienoic Acids Regulate Macrophage Polarization and Prevent LPS‐Induced Cardiac Dysfunction

  2015cited by this paper
• Dietary ω3 fatty acid exerts anti-allergic effect through the conversion to 17,18-epoxyeicosatetraenoic acid in the gut

  2015cited by this paper
• EPA, not DHA, prevents fibrosis in pressure overload-induced heart failure: potential role of free fatty acid receptor 4[S]

  2015influential reference
• Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction

  2015cited by this paper
• Characterizing pharmacological ligands to study the long‐chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4

  2015cited by this paper
• Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction: Contributions of Collagen and Titin

  2015cited by this paper
• Developing therapies for heart failure with preserved ejection fraction: current state and future directions.

  2014influential reference
• New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.

  2014cited by this paper
• Effects of eicosapentaenoic acid on the levels of inflammatory markers, cardiac function and long-term prognosis in chronic heart failure patients with dyslipidemia.

  2014cited by this paper
• Murine models of diastolic dysfunction and heart failure with preserved ejection fraction.

  2014cited by this paper
• Oral administration of eicosapentaenoic acid or docosahexaenoic acid modifies cardiac function and ameliorates congestive heart failure in male rats.

  2014cited by this paper
• GPR120 agonism as a countermeasure against metabolic diseases.

  2014cited by this paper
• Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.

  2014cited by this paper
• Treatment with omega-3 fatty acid ethyl-ester alters fatty acid composition of lipoproteins in overweight or obese adults with insulin resistance.

  2014cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• Fish oil-enriched diet protects against ischemia by improving angiogenesis, endothelial progenitor cell function and postnatal neovascularization.

  2013cited by this paper
• A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.

  2013cited by this paper
• Docosahexaenoic Acid Supplementation Alters Key Properties of Cardiac Mitochondria and Modestly Attenuates Development of Left Ventricular Dysfunction in Pressure Overload-Induced Heart Failure

  2013cited by this paper
• Omega-3 fatty acid supplementation and cardiovascular disease events.

  2013cited by this paper
• Omega-3 fatty acid supplementation and cardiovascular disease events.

  2013cited by this paper
• Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.

  2013cited by this paper
• The role of n-3 polyunsaturated fatty acids in human heart failure.

  2013cited by this paper
• Omega-3 fatty acid supplementation and cardiovascular disease events.

  2013cited by this paper
• Omega-3 Fatty Acid Blood Levels: Clinical Significance and Controversy

  2013cited by this paper
• Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

  2013cited by this paper
• Determinants of Erythrocyte Omega‐3 Fatty Acid Content in Response to Fish Oil Supplementation: A Dose–Response Randomized Controlled Trial

  2013cited by this paper
• Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on plasma and red blood cell fatty acids in patients with very high triglyceride levels (results from the MARINE study).

  2013cited by this paper
• Omega-3 fatty acid supplementation and cardiovascular disease events.

  2013cited by this paper
• n-3 fatty acids in patients with multiple cardiovascular risk factors.

  2013cited by this paper
• Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.

  2013cited by this paper
• Epoxyeicosanoids promote organ and tissue regeneration

  2013cited by this paper
• Differential Signaling by Splice Variants of the Human Free Fatty Acid Receptor GPR120

  2012cited by this paper
• The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.

  2012cited by this paper
• Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction

  2012cited by this paper
• n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

  2012cited by this paper
• Recent developments in myofibroblast biology: paradigms for connective tissue remodeling.

  2012cited by this paper
• Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction: Prevalence, Therapies, and Outcomes

  2012cited by this paper
• Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trial[S]

  2012cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  2012influential reference
• G protein-coupled receptors in human fat taste perception.

  2012cited by this paper
• Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.

  2012cited by this paper
• Biophysical and biochemical mechanisms by which dietary N-3 polyunsaturated fatty acids from fish oil disrupt membrane lipid rafts.

  2012cited by this paper
• Omega-3 fatty acid supplementation and cardiovascular disease

  2012cited by this paper
• Diastolic and Systolic Heart Failure Are Distinct Phenotypes Within the Heart Failure Spectrum

  2011cited by this paper
• Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction

  2011cited by this paper
• Diet-induced Obesity Up-regulates the Abundance of GPR43 and GPR120 in a Tissue Specific Manner

  2011cited by this paper
• Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm study.

  2011cited by this paper
• n-3 Fatty acids in cardiovascular disease.

  2011cited by this paper
• Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy.

  2011cited by this paper
• Circulating Long-Chain ω-3 Fatty Acids and Incidence of Congestive Heart Failure in Older Adults: The Cardiovascular Health Study

  2011cited by this paper
• Dietary fish oil preserves cardiac function in the hypertrophied rat heart

  2011cited by this paper
• Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.

  2011cited by this paper
• Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.

  2011cited by this paper
• Executive Summary: Heart Disease and Stroke Statistics—2015 Update A Report From the American Heart Association

  2011cited by this paper
• n-3 fatty acids in cardiovascular disease.

  2011cited by this paper
• Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction.

  2011cited by this paper
• Omega-3 Fatty Acids Prevent Pressure Overload–Induced Cardiac Fibrosis Through Activation of Cyclic GMP/Protein Kinase G Signaling in Cardiac Fibroblasts

  2011influential reference
• GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects.

  2010cited by this paper
• Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial

  2010cited by this paper
• 17,18-epoxyeicosatetraenoic acid targets PPARγ and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase.

  2010cited by this paper
• n-3 fatty acids and cardiovascular events after myocardial infarction.

  2010cited by this paper
• A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk

  2010cited by this paper
• OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction

  2010influential reference
• Agonism with the omega-3 fatty acids alpha-linolenic acid and docosahexaenoic acid mediates phosphorylation of both the short and long isoforms of the human GPR120 receptor.

  2010cited by this paper
• Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS).

  2009cited by this paper
• Exploiting cGMP-based therapies for the prevention of left ventricular hypertrophy: NO* and beyond.

  2009cited by this paper
• Omega-3 polyunsaturated fatty acids and cardiovascular diseases.

  2009cited by this paper
• Omega‐3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic Review

  2009cited by this paper
• Polyunsaturated fatty acid-cholesterol interactions: domain formation in membranes.

  2009cited by this paper
• Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids.

  2009cited by this paper
• Dietary omega-3 fatty acids alter cardiac mitochondrial phospholipid composition and delay Ca2+-induced permeability transition.

  2009cited by this paper
• Assessing the environment for regulatory change for eicosapentaenoic acid and docosahexaenoic acid nutrition labeling.

  2009cited by this paper
• Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.

  2009cited by this paper
• The cardiac microvasculature in hypertension, cardiac hypertrophy and diastolic heart failure.

  2008cited by this paper
• Effect of fish oil on arrhythmias and mortality: systematic review

  2008cited by this paper
• Docosahexaenoic acid domains: the ultimate non-raft membrane domain.

  2008cited by this paper
• Irbesartan in patients with heart failure and preserved ejection fraction.

  2008cited by this paper
• Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

  2008cited by this paper
• Bioactive dietary long-chain fatty acids: emerging mechanisms of action.

  2008cited by this paper
• Atrial Natriuretic Peptide Inhibits Transforming Growth Factor β–Induced Smad Signaling and Myofibroblast Transformation in Mouse Cardiac Fibroblasts

  2008cited by this paper
• Cloning and characterization of the rat free fatty acid receptor GPR120: in vivo effect of the natural ligand on GLP-1 secretion and proliferation of pancreatic β cells

  2008cited by this paper
• Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions.

  2008cited by this paper
• Cyclic GMP/protein kinase G phosphorylation of Smad3 blocks transforming growth factor-beta-induced nuclear Smad translocation: a key antifibrogenic mechanism of atrial natriuretic peptide.

  2008cited by this paper
• Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events.

  2007cited by this paper
• Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.

  2007influential reference
• How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.

  2007cited by this paper
• Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.

  2007cited by this paper
• ECM remodeling in hypertensive heart disease.

  2007cited by this paper
• Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.

  2007cited by this paper
• Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure

  2006cited by this paper
• Trends in prevalence and outcome of heart failure with preserved ejection fraction.

  2006cited by this paper

• The role of free‐fatty acid receptors FFA1 and FFA4 in organ fibrosis

  2026cites this paper
• Lipid droplets beyond storage: Cellular metabolic modulator in the diabetic heart (Review)

  2026cites this paper
• Association of dietary omega-3 fatty acids intake with all-cause and cardiovascular disease-specific mortality among individuals with cardiovascular disease

  2025cites this paper
• The crosstalk between mitochondrial dysfunction and fatty acid metabolism in heart failure: mechanisms and therapeutic strategies

  2025cites this paper
• Molecular mechanisms of aberrant fatty acids metabolism in driving cardiovascular diseases: key regulatory targets and dietary interventions.

  2025cites this paper
• Eco-Friendly Extraction and Formulation of Black Sea Shark Liver Oil-Based Emulgel for Anti-Inflammatory and Healing Dermatocosmetic Applications

  2025cites this paper
• Daily Consumption of α-Linolenic Acid Increases Conversion Efficiency to Eicosapentaenoic Acid in Mice

  2024cites this paper
• Palm oil as part of a high-fat diet: advances and challenges, or possible risks of pathology?

  2024cites this paper
• Sustainable pig diets: partial grain replacement with former food products and its impact on meat quality

  2024cites this paper
• Free fatty acid receptor 4 in cardiac myocytes ameliorates ischemic cardiomyopathy

  2024cites this paper
• Association of Plasma Omega-3 Levels With Incident Heart Failure and Related Mortalities.

  2024cites this paper
• Eurasian clinical practice guidelines for dietary management of cardiovascular diseases (2024)

  2024cites this paper
• Lipoprotection in cardiovascular diseases.

  2024cites this paper
• Omega-3 PUFAs’ efficacy in the therapy of coronary artery disease combined with anxiety or depression: a meta-analysis

  2024cites this paper
• Eicosapentaenoic acid and Arachidonic acid Protection Against Left Ventricle Pathology: the Multi-Ethnic Study of Atherosclerosis

  2024cites this paper
• The Role of Omega-3 in Attenuating Cardiac Remodeling and Heart Failure through the Oxidative Stress and Inflammation Pathways

  2023cites this paper
• Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis

  2023cites this paper
• Effects of Pig Dietary n-6/n-3 Polyunsaturated Fatty Acids Ratio and Gender on Carcass Traits, Fatty Acid Profiles, Nutritional Indices of Lipid Depots and Oxidative Stability of Meat in Medium–Heavy Pigs

  2023cites this paper
• Effects of Different Dietary Energy Levels on Development, Quality of Carcass and Meat, and Fatty Acid Profile in Male Lambs

  2023cites this paper
• The Association of Metabolomic Profiles of a Healthy Lifestyle with Heart Failure Risk in a Prospective Study

  2023cites this paper
• Comparison of the nutritional quality and the fat globule size after six months of lactation of donkey and human milk

  2023cites this paper
• FFAR4 regulates cardiac oxylipin balance to promote inflammation resolution in HFpEF secondary to metabolic syndrome

  2023cites this paper
• Dietary fatty acids and mortality risk from heart disease in US adults: an analysis based on NHANES

  2023cites this paper
• Omega-3 Polyunsaturated Fatty Acids—Vascular and Cardiac Effects on the Cellular and Molecular Level (Narrative Review)

  2022cites this paper
• Cardiac metabolism in HFpEF: from fuel to signalling.

  2022cites this paper
• Integrated lipidomic and transcriptomic analyses reveal the mechanism of large yellow croaker roe phospholipids on lipid metabolism in normal-diet mice.

  2022cites this paper
• The Modern Aspects of Nutrition during Chronic Heart Failure

  2022cites this paper
• Clinical significance of polyunsaturated fatty acids in the prevention of cardiovascular diseases

  2022cites this paper
• Signaling through free fatty acid receptor 4 attenuates cardiometabolic disease.

  2022cites this paper
• Changes in Serum Fatty Acid Composition and Metabolome-Microbiome Responses of Heigai Pigs Induced by Dietary N-6/n-3 Polyunsaturated Fatty Acid Ratio

  2022cites this paper
• Free fatty acid receptor 4 (FFAR4) regulates cardiac oxylipin balance to promote inflammation resolution in a model of heart failure preserved ejection fraction secondary to metabolic syndrome

  2022cites this paper
• Long-chain omega-3 polyunsaturated fatty acids and the risk of heart failure

  2022cites this paper
• Qualitative and Quantitative Effects of Fatty Acids Involved in Heart Diseases

  2022cites this paper
• PUFA Supplementation and Heart Failure: Effects on Fibrosis and Cardiac Remodeling

  2021cites this paper
• Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure

  2021cites this paper
• Childhood overeating is associated with adverse cardiometabolic and inflammatory profiles in adolescence

  2021cites this paper
• Effect of cow’s milk with different PUFA n-6: n-3 ratios on performance, serum lipid profile, and blood parameters of grower gilts

  2021cites this paper
• Lipids and Cardiovascular Health

  2020cites this paper
• Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments

  2020cites this paper
• Therapeutic Effects of Specialized Pro-Resolving Lipids Mediators on Cardiac Fibrosis via NRF2 Activation

  2020cites this paper
• Effects of Roughage Quality and Particle Size on Rumen Parameters and Fatty Acid Profiles of Longissimus Dorsi Fat of Lambs Fed Complete Feed

  2020cites this paper
• Interaction between Statins and Omega 3 Poly-unsaturated Fatty Acids in Cardiovascular Disease: Synergistic or Not?

  2020cites this paper
• Low Dietary n-6/n-3 PUFA Ratio Regulates Meat Quality, Reduces Triglyceride Content, and Improves Fatty Acid Composition of Meat in Heigai Pigs

  2020cites this paper
• The Anti-Inflammatory and Antioxidant Properties of n-3 PUFAs: Their Role in Cardiovascular Protection

  2020cites this paper
• A novel eicosapentaenoic acid-derived anti-inflammatory lipid mediator 5,6-DiHETE is abundant in blue back fish intestines.

  2020cites this paper
• Effect of breed on meat quality and global acceptance of native lambs and their crosses

  2020cites this paper
• Prevention of Endothelial Dysfunction and Cardiovascular Disease by n-3 Fatty Acids-Inhibiting Action on Oxidative Stress and Inflammation.

  2020cites this paper
• Participation of the nucleus accumbens dopaminergic system in the antidepressant-like actions of a diet rich in omega-3 polyunsaturated fatty acids

  2020cites this paper
• Effects of dietary n-3 polyunsaturated fatty acids on cardiovascular disease

  2020cites this paper
• Omega-3 Fatty Acids

  2019cites this paper
• Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs

  2019cites this paper
• Calanus oil in the treatment of obesity-related low-grade inflammation, insulin resistance, and atherosclerosis

  2019cites this paper
• Expression and Secretion of an Atrial Natriuretic Peptide in Beige-Like 3T3-L1 Adipocytes

  2019cites this paper
• Genome-Wide Assessment for Resting Heart Rate and Shared Genetics With Cardiometabolic Traits and Type 2 Diabetes.

  2019cites this paper
• Heart Histopathology and Mitochondrial Ultrastructure in Aged Rats Fed for 24 Months on Different Unsaturated Fats (Virgin Olive Oil, Sunflower Oil or Fish Oil) and Affected by Different Longevity

  2019cites this paper
• Free fatty acid receptor 4 is a nutrient sensor that resolves inflammation to maintain cardiac homeostasis

  2019cites this paper
• Predicting Risk for Incident Heart Failure With Omega-3 Fatty Acids: From MESA.

  2019cites this paper
• Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue.

  2019cites this paper
• Enhancing Omega-3 Long-Chain Polyunsaturated Fatty Acid Content of Dairy-Derived Foods for Human Consumption

  2019cites this paper
• Cardioprotective effects of omega-3 fatty acids and ascorbic acid improve regenerative capacity of embryonic stem cell-derived cardiac lineage cells.

  2019cites this paper
• In vitro effect of flaxseed oil and α-linolenic acid against the toxicity of lipopolysaccharide (LPS) to human umbilical vein endothelial cells

  2018cites this paper
• Photo and thermal stress of linseed oil and stabilization strategies

  2018cites this paper
• The Functional Role of Zinc Finger E Box-Binding Homeobox 2 (Zeb2) in Promoting Cardiac Fibroblast Activation

  2018cites this paper
• Lower Circulating Omega-3 Polyunsaturated Fatty Acids Are Associated with Coronary Microvascular Dysfunction Evaluated by Hyperemic Microvascular Resistance in Patients with Stable Coronary Artery Disease.

  2018cites this paper
• Identification of plasma interleukins as biomarkers for deflazacort and omega‐3 based Duchenne muscular dystrophy therapy

  2018cites this paper
• Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits.

  2018cites this paper
• FFA4/GPR120: Pharmacology and Therapeutic Opportunities

  2017cites this paper
• Effects of aspirin in combination with EPA and DHA on HDL-C cholesterol and ApoA1 exchange in individuals with type 2 diabetes mellitus.

  2017cites this paper
• Docosahexaenoic acid regulates vascular endothelial cell function and prevents cardiovascular disease

  2017cites this paper
• FFA 4 / GPR 120 : Pharmacology and Therapeutic Opportunities

  2017cites this paper
• Nutritional enhancement of sheep meat fatty acid profile for human health and wellbeing.

  2017cites this paper